Results 11 to 20 of about 40,345 (254)
In this article, we report a case of Coats' disease, a rare idiopathic disorder leading to complete or partial blindness in children who did not receive adequate and timely treatment for several years. We cover the hypotheses of pathogenesis, classification, basic principles of diagnosis (including differential diagnosis), and treatment of exudative ...
V.K. Sevostyanov +2 more
core +5 more sources
iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease. [PDF]
Coats' disease is an uncommon form of retinal telangiectasis, and the identification of novel proteins that contribute to the development of Coats' disease is useful for improving treatment efficacy.
Qiong Yang +4 more
doaj +2 more sources
Coats′ disease of adult-onset in 48 eyes [PDF]
Background: Coats′ disease diagnosed in adulthood is an idiopathic, retinal exudative vascular disease without an inciting factor and has retinal features different from the childhood disease.
Ekta Rishi +5 more
doaj +2 more sources
Clinical-histopathological correlation in a case of Coats' disease
Background Coats' disease is a non-hereditary ocular disease, with no systemic manifestation, first described by Coats in 1908. It occurs more commonly in children and has a clear male predominance.
Zajdenweber Moyses E +5 more
doaj +3 more sources
Adult onset coats disease in a 56-year-old male: An atypical presentation
Coats disease is a congenital retinal vascular disease, which is seen commonly in childhood and remits and exacerbates throughout life. However, it is not rare for coats disease to present in adulthood for the first time.
Bodhraj Dhawan +3 more
doaj +2 more sources
Vitrectomy for epiretinal membrane in adult-onset Coats' disease
Coats' disease is characterized by retinal vascular telangiectasia and subretinal and intraretinal exudation. A relatively benign form of the disease that occurs in adults is referred to as adult-onset Coats' disease. Involvement of macula in the form of
Pradeep Kumar, Vinod Kumar
doaj +2 more sources
Serum hypercoagulability states in Coats’ disease
Fariba Ghassemi,1 Carol L Shields,2 Masoumeh Mohebbi,1 Mehdi Nili Ahmadabadi,1 Fatemeh Morsali,1 Siamak Sabour3,4 1Ocular Oncology and Retina and Vitreous Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; 2Ocular ...
Ghassemi F +5 more
doaj +1 more source
Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease
Purpose: To report a case of rapid “epiretinal membrane” (“ERM”) development following intravitreal bevacizumab for juvenile Coats' disease. Observations: A 7-year old boy was followed for four years with asymptomatic stage 2 Coats' disease in his left ...
Andrew W. Kam +3 more
doaj +2 more sources
Coats disease in infants, toddlers, and preschoolers: Clinical presentation and treatment outcomes [PDF]
Purpose: To study the stage of presentation, clinical features, and treatment outcomes of patients diagnosed with Coats disease in infants, toddlers, and preschoolers (aged ≤5 years).
Saarang Hansraj +2 more
doaj +2 more sources
Over 10 years follow-up of Coats' disease in adulthood
Tatsuro Otani1, Kanako Yasuda1, Naoko Aizawa2, Fumiaki Sakai3, Toru Nakazawa2, Masahiko Shimura11Department of Ophthalmology, NTT East Japan Tohoku Hospital, 2Department of Ophthalmology, Tohoku University School of Medicine, 3Heisei Ophthalmic ...
Otani T +5 more
doaj +1 more source

